The Skinuva line of Growth Factor-based products was founded by Dr. Christopher Zoumalan, a Board-Certified Ophthalmic Plastic and Reconstructive Surgeon. Inspired by his passion for science and medicine, he has dedicated the past several years researching wound-healing, hyperpigmentation and other skin issues to develop the most advanced skin care products for his patients, colleagues and others.

Although there have been major medical advancements in surgical procedures to minimize scarring, patients are still faced with concerns of visible scars that remain post-surgery.

Since the introduction of silicone scar products in the late 1990's there have been limited advancements in the topical scar therapy industry. Dr. Zoumalan and his team of scientists reviewed all the latest advancements in wound healing and incorporated the science from medical literature and clinical studies into developing his new products.

.

Specific ingredients such as selective synthetic Growth Factors were incorporated into the proprietary formulation of Skinuva^® Scar to create what is now recognized as one of the most advanced topical scar creams. Skinuva^® Scar is the first and only scar cream in the industry to use selective Growth Factors in its formulation.

Fetal scarless healing is widely published and occurs due to a complex upregulation and downregulation of certain growth factors. By utilizing such knowledge, Skinuva's team of scientists, clinicians, stem cell experts, and chemists were able to formulate their first product in the Growth Factor pipeline: Skinuva® Scar.

Consumers have long wanted a safe and effective non-hydroquinone (HQ) product to help improve their hyperpigmentation. Hydroquinone and other skin brighteners that perhaps include retinol and other potentially irritating ingredients may be associated with inflammation, dermatitis, and non-compliance. Skinuva^® Brite is a non-HQ Growth Factor-based product along with Tranexamic Acid, Arbutin, Vitamin C, and Niacinimide (Vitamin B3) that has been shown to be nearly 30% more effective in improving hyperpigmentation than HQ 4% in our recent head-to-head clinical trial.* Skinuva^® Brite is also well tolerated with minimal irritation and redness.*

Utilizing the same rigorous methodology of medical literature and clinical data, Skinuva’s team of doctors and scientists were able to develop a unique and patented formula to meet the unmet need for a safe and effective non-hydroquinone topical product. Skinuva^® Brite is a revolutionary Growth-Factor based product that integrates selective ingredients to create what is now regarded as one of the most advanced topical creams for hyperpigmentation.